Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
BBIO BridgeBio Pharma
- 26.490
- +0.280+1.07%
Close Dec 20 16:00 ET
- 26.490
- 0.0000.00%
Post 20:01 ET
5.01BMarket Cap-10.95P/E (TTM)
26.900High26.020Low4.20MVolume26.040Open26.210Pre Close111.29MTurnover3.27%Turnover RatioLossP/E (Static)188.99MShares44.32052wk High-4.07P/B3.40BFloat Cap21.62052wk Low--Dividend TTM128.42MShs Float73.500Historical High--Div YieldTTM3.36%Amplitude4.980Historical Low26.520Avg Price1Lot Size
About BridgeBio Pharma Company
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.
Company Profile
SymbolBBIO
Company NameBridgeBio Pharma
Listing DateJun 27, 2019
Issue Price17.00
Founded2015
CEODr. Neil Kumar, PhD
MarketNASDAQ
Employees556
Fiscal Year Ends12-31
Address3160 Porter Drive,Suite 250
CityPalo Alto
ProvinceCalifornia
CountryUnited States of America
Zip Code94304
Phone1-650-391-9740
Websitehttp://www.bridgebio.com
Company Executives
- Name
- Position
- Salary
- Dr. Neil Kumar, PhD
- Director and Chief Executive Officer of the Company and Eidos Therapeutics, Inc.
- 12.16M
- Dr. Brian C. Stephenson, PhD
- Secretary, Chief Financial Officer and Principal Accounting Officer
- 6.65M
- Dr. Thomas Trimarchi, PhD
- President and Chief Operating Officer
- --
- Dr. Charles J. Homcy,M.D.
- Lead Independent Director and Chairman of Pharmaceuticals
- 1.11M
- Dr. Richard H. Scheller, PhD
- Chairman of Research & Development
- 2.01M
- Dr. Frank P. McCormick, D.Sc.
- Director
- 1.74M
- James C. Momtazee
- Independent Director
- 600.00K
- Fred Hassan
- Independent Director
- 600.00K
- Douglas A. Dachille
- Independent Director
- 600.00K
- Dr. Randal W. Scott,PhD
- Independent Director
- 600.00K
- Dr. Hannah A. Valantine, M.D.
- Independent Director
- 600.00K
- Jennifer E. Cook
- Independent Director
- 600.00K
- Ronald J. Daniels
- Independent Director
- 600.00K
- Ali J. Satvat
- Independent Director
- 600.00K
- Dr. Eric Aguiar, M.D.
- Independent Director
- 600.00K
- Dr. Andrew W. Lo
- Independent Director
- 600.00K
- Andrea John Ellis
- Independent Director
- 600.00K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.